BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 26154417)

  • 1. Human Genome Editing and Ethical Considerations.
    Krishan K; Kanchan T; Singh B
    Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline Editing: Editors Cautionary.
    Krishan K; Kanchan T; Singh B; Baryah N; Puri S
    Clin Ter; 2018; 169(2):e58-e59. PubMed ID: 29595865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
    Bellver Capella V
    Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical Issues of Using CRISPR Technologies for Research on Military Enhancement.
    Greene M; Master Z
    J Bioeth Inq; 2018 Sep; 15(3):327-335. PubMed ID: 29968018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New gene editing technique CRISPR-Cas9 raises important ethical questions, says advisory body.
    Hawkes N
    BMJ; 2016 Sep; 354():i5318. PubMed ID: 27694221
    [No Abstract]   [Full Text] [Related]  

  • 6. Shaping the CRISPR Gene-Editing Debate: Questions About Enhancement and Germline Modification.
    Johnston J
    Perspect Biol Med; 2020; 63(1):141-154. PubMed ID: 32063593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.
    Musunuru K
    J Am Coll Cardiol; 2017 Dec; 70(22):2808-2821. PubMed ID: 29191331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethics of Human Genome Editing.
    Coller BS
    Annu Rev Med; 2019 Jan; 70():289-305. PubMed ID: 30691366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia?
    Burbery R
    J Law Med; 2020 Apr; 27(3):718-740. PubMed ID: 32406632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool.
    Brokowski C; Adli M
    J Mol Biol; 2019 Jan; 431(1):88-101. PubMed ID: 29885329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing Ethical Trials of Germline Gene Editing.
    Cwik B
    N Engl J Med; 2017 Nov; 377(20):1911-1913. PubMed ID: 29141166
    [No Abstract]   [Full Text] [Related]  

  • 14. CRISPR/Cas 9 genome editing and its applications in organoids.
    Driehuis E; Clevers H
    Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G257-G265. PubMed ID: 28126704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who Goes First? Deaf People and CRISPR Germline Editing.
    Padden C; Humphries J
    Perspect Biol Med; 2020; 63(1):54-65. PubMed ID: 32063586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical issues of CRISPR technology and gene editing through the lens of solidarity.
    Mulvihill JJ; Capps B; Joly Y; Lysaght T; Zwart HAE; Chadwick R;
    Br Med Bull; 2017 Jun; 122(1):17-29. PubMed ID: 28334154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethics assessment in research proposals adopting CRISPR technology.
    Hirsch F; Iphofen R; Koporc Z
    Biochem Med (Zagreb); 2019 Jun; 29(2):020202. PubMed ID: 31223254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. With First CRISPR Trials, Gene Editing Moves Toward the Clinic.
    Hampton T
    JAMA; 2020 Apr; 323(16):1537-1539. PubMed ID: 32267478
    [No Abstract]   [Full Text] [Related]  

  • 20. Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.
    Schleidgen S; Dederer HG; Sgodda S; Cravcisin S; Lüneburg L; Cantz T; Heinemann T
    BMC Med Ethics; 2020 Sep; 21(1):87. PubMed ID: 32912206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.